These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6244483)

  • 1. Immunologic properties of protein-linopolysaccharide complexes--III. Role of carbohydrate in the LPS adjuvant effect.
    Scibienski RJ
    Mol Immunol; 1980 Jan; 17(1):21-7. PubMed ID: 6244483
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of O-antigen polysaccharide in the activation of neutrophils by lipopolysaccharides of Salmonella species.
    Rasool O; Nnalue NA; Jarstrand C
    Clin Exp Immunol; 1992 Oct; 90(1):63-7. PubMed ID: 1382904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the saccharide chain length of bacterial lipopolysacchrides on the stimulation of immune system].
    Lallier R; Nigam VN; Brailovsky CA
    Can J Microbiol; 1979 May; 25(5):640-1. PubMed ID: 476544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of T-independent antibody responses by hapten-lipopolysaccharides without repeating polymeric structure.
    Skelly RR; Munkenbeck P; Morrison DC
    Infect Immun; 1979 Feb; 23(2):287-93. PubMed ID: 311343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel adjuvant action of lipopolysaccharides that possess mannose homopolysaccharides as O-specific polysaccharides on immune responses to nonimmunogenic autoantigens in mice.
    Yokochi T; Fukada M; Kawai M; Zhang YH; Jiang GZ; Takahashi K
    Infect Immun; 1992 Nov; 60(11):4953-6. PubMed ID: 1383160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide of Legionella as adjuvant for intrinsic and extrinsic antigens.
    Wong KH; Feeley JC
    Proc Soc Exp Biol Med; 1984 Dec; 177(3):475-81. PubMed ID: 6514722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the mannan O side-chains to the adjuvant action of lipopolysaccharides.
    Ohta M; Kido N; Hasegawa T; Ito H; Fujii Y; Arakawa Y; Komatsu T; Kato N
    Immunology; 1987 Apr; 60(4):503-7. PubMed ID: 2438205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome potentiation of humoral immune response to lipopolysaccharide and O-polysaccharide antigens of Brucella abortus.
    Wong JP; Cherwonogrodzky JW; Di Ninno VL; Stadnyk LL; Knodel MH
    Immunology; 1992 Sep; 77(1):123-8. PubMed ID: 1398758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective suppression of primary IgM responses by induction of low dose paralysis to type III pneumococcal polysaccharide.
    Braley-Mullen H
    Cell Immunol; 1978 Apr; 37(1):77-85. PubMed ID: 26471
    [No Abstract]   [Full Text] [Related]  

  • 10. Strong adjuvanticity of bacterial lipopolysaccharides possessing the homopolysaccharides consisting of mannose as the O-specific polysaccharide chains.
    Kato N; Ohta M; Kido N; Naito S; Nakashima I; Nagase F; Yokochi T
    Med Microbiol Immunol; 1985; 174(1):1-14. PubMed ID: 3889573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant and immunogenic properties of bacterial lipopolysaccharide in IgE and IgG antibody formation in mice.
    Danneman PJ; Michael JG
    Cell Immunol; 1976 Mar; 22(1):128-39. PubMed ID: 776412
    [No Abstract]   [Full Text] [Related]  

  • 12. Recognition of a carbohydrate antigenic determinant of Salmonella by an antibody.
    Cygler M; Wu S; Zdanov A; Bundle DR; Rose DR
    Biochem Soc Trans; 1993 May; 21(2):437-41. PubMed ID: 7689495
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the MER tubercle bacillus fraction on the responsiveness of mice to T-independent antigens.
    Ben-Efraim S; Ophir R; Teitelbaum R; Zimber C; Barbash G; Weiss DW
    Int Arch Allergy Appl Immunol; 1979; 58(1):110-8. PubMed ID: 370026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mode of action of immunological adjuvants. II. Generation of a potent precursor of antibody-forming cell by adjuvant.
    Ishibashi T; Tanaka A; Koashi O; Sugiyama K
    Jpn J Exp Med; 1975 Jun; 45(3):147-54. PubMed ID: 809607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive substances of mycobacteria.
    Goren MB
    Am Rev Respir Dis; 1982 Mar; 125(3 Pt 2):50-69. PubMed ID: 6176156
    [No Abstract]   [Full Text] [Related]  

  • 16. Potent adjuvant action of lipopolysaccharides possessing the O-specific polysaccharide moieties consisting of mannans in antibody response against protein antigen.
    Kido N; Ohta M; Ito H; Naito S; Nagase F; Nakashima I; Kato N
    Cell Immunol; 1985 Mar; 91(1):52-9. PubMed ID: 2578897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic properties of bacterial lipopolysaccharides treated with chromium chloride.
    Snyder SL; Walker RI; MacVittie TJ; Sheil JM
    Can J Microbiol; 1978 May; 24(5):495-501. PubMed ID: 350361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological activities of bacterial lipopolysaccharide (author's transl)].
    Nakano M
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():269-82. PubMed ID: 800279
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical contribution of both CD28 and ICOS in the adjuvant activity of Neisseria meningitidis H44/76 LPS and lpxL1 LPS.
    van Berkel ME; Schrijver EH; van Mourik A; Tesselaar K; van der Ley P; Steeghs L; Oosterwegel MA
    Vaccine; 2007 Jun; 25(24):4681-8. PubMed ID: 17499399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.